| |
| |
|
| Insider
Information: |
El Coronado Holdings, Llc |
| Relationship: |
10% Owner |
| City: |
Pearce |
| State: |
AZ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
6,674,725 |
|
|
Indirect Shares
|
27,131,085 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$11,687,847 |
|
|
| Total
Shares |
33,805,810 |
|
|
| Total
Value |
$11,687,847 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Nmi Health Inc |
NANM |
10% Owner |
2005-03-02 |
0 |
2009-06-22 |
9,805,857 |
Premium* |
|
|
Novogen Limited (ADR) |
NVGN |
10% Owner |
2006-04-21 |
0 |
2013-11-05 |
385,749 |
Premium* |
|
|
Chelsea Therapeutics Internation... |
CHTP |
10% Owner |
2007-03-22 |
0 |
2012-12-17 |
6,432,673 |
Premium* |
|
|
MEI Pharma Inc |
MEIP |
10% Owner |
2012-12-03 |
0 |
2012-12-03 |
3,832,081 |
Premium* |
|
|
Protea Biosciences Group Inc |
PRGB |
10% Owner |
2013-12-30 |
6,674,725 |
2013-12-30 |
6,674,725 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PRGB |
Protea Biosciences Group ... |
10% Owner |
– – • |
2013-12-30 |
5 |
B |
$0.50 |
$127,292 |
I/I |
254,584 |
6,674,725 |
0 |
- |
|
| PRGB |
Protea Biosciences Group ... |
10% Owner |
– – • |
2013-12-30 |
5 |
B |
$0.50 |
$127,292 |
D/D |
254,584 |
6,674,725 |
0 |
- |
|
| PRGB |
Protea Biosciences Group ... |
10% Owner |
– – • |
2013-12-30 |
4 |
B |
$0.50 |
$127,292 |
D/D |
254,584 |
6,674,725 |
2.45 |
- |
|
| PRGB |
Protea Biosciences Group ... |
10% Owner |
– – • |
2013-12-30 |
4 |
B |
$0.50 |
$127,292 |
I/I |
254,584 |
6,674,725 |
1.5 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2013-11-05 |
4 |
S |
$6.01 |
$143,690 |
I/I |
(23,922) |
385,749 |
0 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2013-11-04 |
4 |
S |
$6.02 |
$153,032 |
I/I |
(25,400) |
409,671 |
0 |
- |
|
| PRGB |
Protea Biosciences Group ... |
10% Owner |
– – • |
2013-11-01 |
5 |
B |
$0.50 |
$1,185,847 |
D/D |
2,371,694 |
6,420,141 |
0 |
- |
|
| PRGB |
Protea Biosciences Group ... |
10% Owner |
– – • |
2013-11-01 |
4 |
B |
$0.50 |
$1,185,847 |
I/I |
2,371,694 |
6,420,141 |
1.5 |
- |
|
| PRGB |
Protea Biosciences Group ... |
10% Owner |
– – • |
2013-11-01 |
4 |
B |
$0.50 |
$1,185,847 |
D/D |
2,371,694 |
6,420,141 |
2.45 |
- |
|
| PRGB |
Protea Biosciences Group ... |
10% Owner |
– – • |
2013-11-01 |
5 |
B |
$0.50 |
$1,185,847 |
I/I |
2,371,694 |
6,420,141 |
0 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2013-10-29 |
4 |
S |
$6.04 |
$6,641 |
I/I |
(1,100) |
435,071 |
0 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2013-10-28 |
4 |
S |
$6.18 |
$231,236 |
I/I |
(37,409) |
436,171 |
0 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2013-10-25 |
4 |
S |
$6.17 |
$386,337 |
I/I |
(62,591) |
473,580 |
0 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2013-10-15 |
4 |
S |
$6.21 |
$559,208 |
I/I |
(90,025) |
536,171 |
0 |
- |
|
| PRGB |
Protea Biosciences Group ... |
10% Owner |
– – • |
2013-06-30 |
4 |
B |
$0.50 |
$131,202 |
D/D |
262,403 |
4,048,447 |
2.45 |
- |
|
| PRGB |
Protea Biosciences Group ... |
10% Owner |
– – • |
2013-06-30 |
4 |
B |
$0.50 |
$131,202 |
I/I |
262,403 |
4,048,447 |
1.5 |
- |
|
| PRGB |
Protea Biosciences Group ... |
10% Owner |
– – • |
2013-04-05 |
4 |
B |
$0.50 |
$140,000 |
D/D |
280,000 |
3,786,044 |
2.45 |
- |
|
| PRGB |
Protea Biosciences Group ... |
10% Owner |
– – • |
2013-04-05 |
4 |
B |
$0.50 |
$140,000 |
I/I |
280,000 |
3,786,044 |
1.5 |
- |
|
| PRGB |
Protea Biosciences Group ... |
10% Owner |
– – • |
2013-03-21 |
4 |
B |
$0.50 |
$685,000 |
D/D |
1,370,000 |
3,506,044 |
2.45 |
- |
|
| PRGB |
Protea Biosciences Group ... |
10% Owner |
– – • |
2013-03-21 |
4 |
B |
$0.50 |
$685,000 |
I/I |
1,370,000 |
3,506,044 |
1.5 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2013-02-26 |
4 |
S |
$8.00 |
$4,000 |
I/I |
(500) |
626,196 |
0 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2013-02-25 |
4 |
S |
$8.90 |
$27,220 |
I/I |
(3,000) |
626,696 |
0 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2012-12-17 |
4 |
S |
$0.92 |
$402,055 |
I/I |
(439,308) |
6,432,673 |
0 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2012-12-14 |
4 |
S |
$0.95 |
$236,811 |
I/I |
(249,249) |
6,871,981 |
0 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2012-12-12 |
4 |
S |
$1.05 |
$419,385 |
I/I |
(399,414) |
7,121,230 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
